- Home
- CTSO vs WETO Comparison
CTSO vs WETO Comparison
Compare CTSO & WETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- WETO
- Stock Information
- Founded
- CTSO 1997
- WETO 2019
- Country
- CTSO United States
- WETO China
- Employees
- CTSO N/A
- WETO N/A
- Industry
- CTSO Medical/Dental Instruments
- WETO
- Sector
- CTSO Health Care
- WETO
- Exchange
- CTSO Nasdaq
- WETO NYSE
- Market Cap
- CTSO 68.2M
- WETO 81.4M
- IPO Year
- CTSO N/A
- WETO 2025
- Fundamental
- Price
- CTSO $0.87
- WETO $3.81
- Analyst Decision
- CTSO Strong Buy
- WETO
- Analyst Count
- CTSO 3
- WETO 0
- Target Price
- CTSO $4.67
- WETO N/A
- AVG Volume (30 Days)
- CTSO 138.6K
- WETO 20.7K
- Earning Date
- CTSO 05-14-2025
- WETO 01-01-0001
- Dividend Yield
- CTSO N/A
- WETO N/A
- EPS Growth
- CTSO N/A
- WETO N/A
- EPS
- CTSO N/A
- WETO N/A
- Revenue
- CTSO $35,594,520.00
- WETO $6,326,827.00
- Revenue This Year
- CTSO $18.72
- WETO N/A
- Revenue Next Year
- CTSO $19.75
- WETO N/A
- P/E Ratio
- CTSO N/A
- WETO N/A
- Revenue Growth
- CTSO 14.51
- WETO N/A
- 52 Week Low
- CTSO $0.70
- WETO $3.10
- 52 Week High
- CTSO $1.61
- WETO $4.30
- Technical
- Relative Strength Index (RSI)
- CTSO 34.05
- WETO N/A
- Support Level
- CTSO $0.87
- WETO N/A
- Resistance Level
- CTSO $1.16
- WETO N/A
- Average True Range (ATR)
- CTSO 0.06
- WETO 0.00
- MACD
- CTSO -0.02
- WETO 0.00
- Stochastic Oscillator
- CTSO 0.34
- WETO 0.00
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About WETO WEBUS INTERNATIONAL LIMITED
Webus International Ltd operates on a business model of Mobility-as-a-Service to identify and solve inefficiencies associated with inflexible or low-quality public transportation and provide cost-efficient and customized mass transportation services under different scenarios with comprehensive digital platforms. It offers commute shuttle service, customized chartered bus service, packaged tour service and other service to customers.